FibroBiologics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2023 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
FibroBiologics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2023 to Q4 2024.
  • FibroBiologics, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $588K, a 37.1% increase year-over-year.
  • FibroBiologics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $2.22M, a 25.7% increase year-over-year.
  • FibroBiologics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $2.22M, a 25.7% increase from 2023.
  • FibroBiologics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.77M, a 566% increase from 2022.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $2.22M $588K +$159K +37.1% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-31
Q3 2024 $2.06M $572K +$132K +30% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $1.93M $579K +$131K +29.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $1.8M $480K +$32K +7.14% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $1.77M $429K Oct 1, 2023 Dec 31, 2023 10-K 2025-03-31
Q3 2023 $440K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $448K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $448K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.